Xeltis

About Xeltis

Xeltis is a company focused on developing transformative vascular implants and valves that are replaced by the patient's own living tissue, aiming to address major life-threatening diseases. Their mission is to improve standards of care for millions of patients undergoing vascular surgery by reducing complications and the need for reinterventions, backed by Nobel prize-winning science.

Products & Services

Vascular Implants and Valves:Artificial vessels and valves that are gradually replaced by the patient's own healthy tissue, reducing risks of thrombosis, stenosis, calcification, and infection.

RestoreXTM (ETR Platform):A proprietary Endogenous Tissue Restoration platform used for applications like pulmonary heart valves, hemodialysis access, coronary arterial bypass surgery, and other vascular indications.

Xabg (Coronary Artery Bypass Conduit):A conduit for coronary artery bypass surgery, currently showing positive safety and patency data in clinical trials.

aXess vascular access conduit

ETR-based vascular implants

Pulmonary heart valves

Specialties

Endogenous Tissue Restoration (ETR) Vascular Implants Heart Valves Polymer Technology Coronary Artery Bypass Surgery Hemodialysis Access Pulmonary Heart Valves Hemodialysis access Coronary arterial bypass Peripheral arterial disease

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Venture Debt and Equity T: - FT: Venture Debt and Equity	A: 52250000 MR: - FA: up to €47.5 million FAN: 52250000	D: 2025-12-02 FD: 2025-12-02	3 investors
2	RT: Equity Investment T: - FT: Equity Investment	A: 10800000 MR: - FA: €10 million FAN: 10800000	D: 2025-04-08 FD: 2025-04-08	1 investors

Venture Debt and Equity Latest

2025-12-02

$52.2M

3 investors (Pro only)

Equity Investment 2025-04-08

$10.8M

View 1 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

E

Eliane Schutte

Chief Executive Officer

P

Paulo Neves

Chief Medical Officer

A

Alexander Goemans

Chief Financial Officer

R

Rob Eyers

Chief Technology & Operations Officer

F

Fred Colen

Chairman of the Board

C

Christian Wenger

Board Member

View 28 more team members with Pro

Unlock Full Team Directory

Recent News

Xeltis Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised